Pioglitazone
UTHSCSA IRB# 001-5014-331
Approved small_molecule completed
Quick answer
Pioglitazone for Nonalcoholic Steatohepatitis is a Approved program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Nonalcoholic Steatohepatitis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed